<p>Zentalis Pharmaceuticals Inc. announced that Karan Takhar has resigned from its Board of Directors and all related committees, effective immediately. Following his departure, the board was reduced from seven to six members. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001725160-25-000164), on December 15, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ZNTL

<p>Zentalis Pharmaceuticals Inc. announced the resignation of Karan Takhar from its Board of Directors, reducing the board from seven to six members. The announcement was made via EDGAR by the U.S. Securities and Exchange Commission. This AI-generated news brief is for informational purposes only and not financial advice.</p>

Zentalis Pharmaceuticals Director Karan Takhar Resigns